about
Present and future challenges in the treatment of haemophilia: the patient's perspectiveInsight into molecular changes of the FIX protein in a series of Italian patients with haemophilia B.Clinical Data of Neonatal Systemic Thrombosis.Management of bleeding and of invasive procedures in patients with platelet disorders and/or thrombocytopenia: Guidelines of the Italian Society for Haemostasis and Thrombosis (SISET).Management of chronic childhood immune thrombocytopenic purpura: AIEOP consensus guidelines.Uncovered needs in the management of inherited bleeding disorders in Italy.Hemophilia Care in the Pediatric Age.Conditions associated with infections of indwelling central venous catheters in cancer patients: a summary.Issues in pediatric haemophilia carevon Willebrand factor, von Willebrand factor-cleaving protease, and shear stress.Venous thrombosis in children: an emerging issue.Emerging issues on comprehensive hemophilia care: preventing, identifying, and monitoring age-related comorbidities.Current management of the hemophilic child: a demanding interlocutor. Quality of life and adequate cost-efficacy analysis.A practical approach to the use of low molecular weight heparins in VTE treatment and prophylaxis in children and newborns.Central venous access devices in pediatric malignancies: a position paper of Italian Association of Pediatric Hematology and Oncology.Recommendations for the use of long-term central venous catheter (CVC) in children with hemato-oncological disorders: management of CVC-related occlusion and CVC-related thrombosis. On behalf of the coagulation defects working group and the supportiPaediatric venous thromboembolism: a report from the Italian Registry of Thrombosis in Children (RITI).Diagnosis and management of severe congenital factor XIII deficiency in the Emergency Department: lessons from a "model" family.Brachiocephalic vein for percutaneous ultrasound-guided central line positioning in children: A 20-month preliminary experience with 109 procedures.Germ-line origin of intron 1 inversion in two haemophilia A families.Prophylaxis therapy in paediatric patients with haemophilia: a survey of clinical management trends in Italy.Health economic models in hemophilia A and utility assumptions from a clinician's perspective.Perceived challenges and attitudes to regimen and product selection from Italian haemophilia treaters: the 2013 AICE survey.The increased demand for plasma-derived factor VIII in Italy between 2011 and 2014 is attributable to treatment of adult patients rather than paediatric or previously unexposed patients with severe haemophilia A.Prospective study of hemostatic alterations in children with acute lymphoblastic leukemia.Factor VIII products and inhibitor development in severe hemophilia A.Caspofungin associated with liposomal amphotericin B or voriconazole for treatment of refractory fungal pneumonia in children with acute leukaemia or undergoing allogeneic bone marrow transplant.Successful urgent neurosugery management with rFVIIa mega doses in a child with haemophilia A and high titre inhibitor.Intracranial haemorrhage in children and adolescents with severe haemophilia A or B - the impact of prophylactic treatment.Identification of mutations in exon 14 including five novelties in 13 Italian patients with haemophilia A.Familial nonrandom inactivation linked to the X inactivation centre in heterozygotes manifesting haemophilia A.Forum on: the role of recombinant factor VIII in children with severe haemophilia A.Rituximab-based immunosuppression for autoimmune haemolytic anaemia in infants.Neonatal systemic thrombosis: an updated overview.Sirolimus as maintenance treatment in an infant with life-threatening multiresistant pure red cell anemia/autoimmune hemolytic anemia.Paediatric arterial ischaemic stroke and cerebral sinovenous thrombosis. First report from the Italian Registry of Pediatric Thrombosis (R. I. T. I., Registro Italiano Trombosi Infantili).Incidence of catheter-related infections within 30 days from insertion of Hickman-Broviac catheters.Metabolic and genetic risk factors for migraine in children.Correlation between "malfunctioning events" and catheter-related infections in pediatric cancer patients bearing tunneled indwelling central venous catheter: results of a prospective observational study.Development and definition of a simplified scanning procedure and scoring method for Haemophilia Early Arthropathy Detection with Ultrasound (HEAD-US).
P50
Q27022801-0D5D2AC9-822D-47F6-9CC6-D3E44BD6EE4DQ30354082-460723C6-41C6-445C-A455-BBED53CCEB41Q31038268-C4162E79-E781-46D4-82E1-7CDBA9B06727Q33385523-412048C2-2440-4021-AE4C-A9554E480252Q33387589-C1412C42-182C-4612-93DB-931034355A0AQ33708980-1665A3E5-6F1B-45E8-A27D-11ABAF78512BQ33737259-D3B67701-F5FF-424C-840E-A792F9036170Q35106678-AD314A49-FDE4-4911-B152-F10692A69F7DQ36835166-C92371B1-4946-46FC-9129-3B53E0DA0452Q36990168-94CBDDC9-2116-44C7-90E2-182CB4C1926EQ37890817-DB0CC60B-A13F-4255-9AF4-BAAFBB0D3039Q38135319-65104BF8-20ED-407A-9A15-567869F0C2ADQ38227605-EF0C3E42-1727-41E5-8E9F-002D25238A58Q38261097-FC14AEFA-0C1B-404E-A9C3-5FAB04F4594BQ38264307-547D699B-8F2D-4963-BDDB-FBE88E7137B7Q38572306-61970330-B256-4BC1-B1FD-6BC2A3B537E8Q38661336-0DEE43A2-000E-47F1-A354-011061C9C812Q39218599-2C477D08-1110-4B2F-8F7C-0EC6CA963B41Q40557215-E9655417-7B98-4E64-8F40-85C816BA5EC0Q40594389-FD8C497A-3ACE-4BB5-94C9-2AA6A25A38FCQ40854812-C050691C-D01A-4372-A451-F6D0D071DBF3Q40938357-331AB728-6EC1-4A39-806E-12C6E566C9C2Q42236600-6B1D5EDE-486E-4AE0-813F-CAFF342E4B52Q42345334-E4E9C8DE-096D-476B-B89E-259D77CA3A47Q43082685-557C6FBB-8136-4676-B341-687CBFF22FEEQ43770114-3D177154-7A7E-4CCD-85D8-534F6234BF20Q44791745-CCB1A372-5B53-4383-8969-4DFA3D6B6694Q45862282-A164D80F-1693-486A-9AAF-F7D085D0725AQ45869705-B4F5798B-42AE-4D6B-AE40-8C94CC7BEC89Q45879773-C539D82F-5EB5-4DDE-93E1-A5BFC54F0341Q45881648-B44BB34D-629B-4D09-91F3-4FEFB334801DQ45882925-C2EA27B1-CDC7-4326-9547-873051E3755BQ46126217-55C7D215-C991-46BB-B4F5-347998DEF701Q49971525-7CC78FC0-41D6-434E-85AE-263B50D672B1Q50492335-9022ADBC-177E-45B7-979C-BEF0E336C583Q51136480-56009C48-52BD-4728-B56D-9A400E9A10DAQ51303713-3F1C01FA-D2C3-4AFA-9C79-78B38CB84D84Q51498300-4462C0B4-3C59-41A7-AC5F-BA17CFF6F945Q51515284-899EE021-01EB-499D-91A9-6FA8817B52F5Q53117757-A0973D5D-A5DD-41FD-A1A4-DE29A9FA937C
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Angelo Claudio Molinari
@ast
Angelo Claudio Molinari
@en
Angelo Claudio Molinari
@es
Angelo Claudio Molinari
@nl
type
label
Angelo Claudio Molinari
@ast
Angelo Claudio Molinari
@en
Angelo Claudio Molinari
@es
Angelo Claudio Molinari
@nl
prefLabel
Angelo Claudio Molinari
@ast
Angelo Claudio Molinari
@en
Angelo Claudio Molinari
@es
Angelo Claudio Molinari
@nl
P106
P1153
7103155635
P21
P31
P496
0000-0002-8078-8402